Prevalence and incidence of carbapenem-resistant K. pneumoniae colonization: systematic review and meta-analysis

Tesfa, Tewodros; Mitiku, Habtamu; Edae, Mekuria; Assefa, Nega

doi:10.1186/s13643-022-02110-3

Systematic Reviews

Table 1 Characteristics of studies describing the prevalence and incidence of colonization with carbapenem resistant K. pneumoniae

From: Prevalence and incidence of carbapenem-resistant K. pneumoniae colonization: systematic review and meta-analysis

Authors	Positive	Sample size	Prevalence	Country	Study design	Type of patient	Ward	Site of sample	Genes
Akturk [32]	85	2805	0.03	Turkey	Case-control	Admitted	NICU & PICU	Rectal swab
Al Fadhi [33]	7	590	0.01	Kuwait	Cohort	Admitted + community	M/S ICU (adult)	Rectal swab	OXA-181, KPC-2, VIM-1, NDM-5
Antony [34]	1	154	0.01	India	Cross-sectional	Community		Rectal swab	NDM-1
Atterby [35]	2	307	0.01	Cambodia	Cross-sectional	Community	community	Rectal swab	OXA-48
Baraniak [36]	110	17945	0.01	Europe & Israel	Cohort	Admitted	ICU, RU	Rectal swab	KPC-2, KPC-3
Barbadoro [37]	45	2478	0.02	Italy	Case-control	On Admission		Rectal swab	KPC, VIM
Dubby [38]	21	299	0.07	Israel	Cohort	On admission	ICU	Rectal swab
Errico [39]	58	680	0.09	Italy	Cohort	Admitted	Transplant	Rectal swab	KPC
Ghaith [40]	19	100	0.19	Egypt	Cross-sectional	Admitted	ICU	Rectal swab	NDM-1, VIM, OXA-48,
Giannella [41]	11	237	0.05	Italy	Cohort	On admission	Transplant	Rectal swab
Giannella [42]	38	553	0.07	Italy	Cohort	On admission	Transplant	Rectal swab
Girlich [43]	7	77	0.09	Morocco	Cross-sectional	Admitted		Rectal swab	OXA-48
Kang [44]	16	833	0.02	Korea	Case control	On admission	EICU	Rectal swab	KPC
Kiddee [45]	9	275	0.03	Thailand	Cohort	On admission	ICU	Rectal swab	NDM
Kizilates [46]	11	168	0.07	Turkey	Cross-sectional	On admission		Rectal swab	OXA-48, NDM
Liu [47]	42	704	0.06	China	Cross-sectional	On admission	ICU	Rectal swab	KPC, NDM, IMP
Mammina [48]	31	391	0.08	Italy	Cohort	On admission	ICU	Rectal swab	KPC
Maseda [49]	41	254	0.16	Spain	Cross-sectional	On admission	SICU	Rectal swab	OXA-48,
Mohan [50]	9	232	0.04	India	Cross-sectional	Admitted		Fecal sample	NDM-1, VIM
Ohno [51]	2	1487	0.00	Japan	Cross-sectional	Admitted		Fecal sample
Pan [52]	12	880	0.01	China	Cross-sectional	On admission		Fecal sample	NDM-1, NDM-5, KPC-2, IMP-4
Papadimitriou [53]	40	442	0.09	Greece	Cross-sectional	On admission	ICU	Rectal swab
Prasa d[54]	46	301	0.15	USA	Cross-sectional	Admitted	LTCF	Rectal swab	KPC-2, KPC-3
Qin [55]	37	243	0.15	China	Cohort	On admission	ICU	Rectal swab	KPC-2
Rios [56]	4	501	0.01	Spain	Cross-sectional	Admitted + outpatient		Rectal swab	KPC-2, OXA-48
Salamao [57]	46	676	0.07	Brazil	Cross-sectional	On admission		Rectal swab
Salazar-Ospina [58]	5	210	0.02	Colombia	Cohort	Admitted		Rectal swab
Saseedharan [59]	12	54	0.22	India	Cross-sectional	On admission	ICU	Rectal swab	KPC, NDM, VIM, IMP
Shu [60]	42	202	0.21	China	Cross-sectional	Admitted	ICU	Rectal swab	KPC-2
Tran [61]	260	2233	0.12	Vietnam	Cross-sectional	Admitted	Admitted to hospital	Rectal swab
Wiener [62]	16	298	0.05	Israel	Case-control	Admitted		Rectal swab
Xu [63]	25	1052	0.02	China	Cross-sectional	Admitted		Rectal swab	NDM-5, KPC-2, IMP-4

Back to article page

ISSN: 2046-4053

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com